MedPath

Social cognition in children treated for a brain tumour: A comparative prospective international multi-centre study

Completed
Conditions
neuropsychologische stoornissen
CNS Neoplasm
Cancer
10029211
Registration Number
NL-OMON39404
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
39
Inclusion Criteria

Brain tumour patients:
1) Aged 5-12 years at first assessment
2) Newly diagnosed brain tumour patients that have not yet received adjuvant therapy
3) Stable medical condition;Healthy controls:
1) Aged 5-12 years at first assessment ;CF patients:
1) Aged 5-12 years at first assessment
2) Stable medical condition

Exclusion Criteria

Brain tumour patients:
1) Diagnosed with a disorder of the autistic spectrum, not related to the tumour (Autism, Asperger*s Syndrome or Pervasive Developmental Disorder not otherwise specified).
2) History of other brain disease or neurological condition interfering with normal development.
3) No native Dutch speaker
4) Severe sensory handicaps and/or behavioural problems interfering with reliable neuropsychological assessment
5) IQ below 70
6) Poor prognosis and life expectancy less than 1 year.;Healthy controls:
1) Diagnosed with a disorder of the autistic spectrum (Autism, Asperger*s Syndrome or Pervasive Developmental Disorder not otherwise specified).
2) History of other brain disease or neurological condition interfering with normal development.
3) No native Dutch speaker
4) Severe sensory handicaps and/or behavioural problems interfering with reliable neuropsychological assessment.
5) IQ below 70;CF patients:
1) Diagnosed with a disorder of the autistic spectrum (Autism, Asperger*s Syndrome or Pervasive Developmental Disorder not otherwise specified).
2) History of other brain disease or neurological condition interfering with normal development.
3) No native Dutch speaker
4) Severe sensory handicaps and/or behavioural problems interfering with reliable neuropsychological assessment.
5) IQ below 70

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Change in performance on tests of social cognition from time 1 to time 2. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1) Change in reports of social and emotional functioning of patients<br /><br>themselves, parents and teachers from time 1 to time 2.<br /><br>2) Influence of Individual medical characteristics on the change in performance<br /><br>on tests of social cognition from time 1 to time 2.<br /><br>3) Influence of Socio-economical status (parental education and occupation) on<br /><br>the change in performance on tests of social cognition from time 1 to time 2<br /><br>4) Influence of Intelligence level and Executive Functions on the change in<br /><br>performance on tests of social cognition from time 1 to time 2.</p><br>
© Copyright 2025. All Rights Reserved by MedPath